An NCI-designated Comprehensive Cancer Center

Breakthroughs Blog Old

City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.

Breakthroughs - Stephen Forman 256x256

City of Hope's BMT survival rates exceed expectations for 15 consecutive years

February 14, 2020 | City of Hope

City of Hope’s bone marrow transplantation program has achieved a higher-than-expected survival rate based on a 2019 analysis by the Center for International Blood and Marrow Transplant Research.

Continue Reading

Saswatee Chatterjee

Saswati Chatterjee, Ph.D., Seeks Cure for Hemophilia

February 21, 2018 | Katie Neith

Saswati Chatterjee, Ph.D., a professor in the Department of Surgery and member of Beckman Research Institute of City of Hope, thinks she may know a way to cure hemophilia A.

Continue Reading

Daniel Jae Kim

New Hire: Daniel Jae Kim

January 25, 2018 | City of Hope

Daniel Jae Kim, M.D., is based at City of Hope's South Pasadena facility and specializes in hematology and oncology.

Continue Reading

Larry Kwak

Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work

January 12, 2018 | Letisia Marquez

Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.

Continue Reading

Myeloma Series CAR T Wang homepage image

Multiple Myeloma CAR T Cell Trial to launch in 2017

April 3, 2017 | Travis Marshall

An upcoming phase 1 clinical trial at City of Hope will look at the effects of CAR T cells programmed to target a protein called CS-1, which is found on myeloma cells.

Continue Reading

Alex Herrera

Researchers tackle two difficult-to-treat lymphomas

February 2, 2017 | Letisia Marquez

New study in the Journal of Clinical Oncology concludes that patients with relapsed or treatment-resistant double-hit and/or double-expressor lymphomas didn’t respond as well to the transplantation as diffuse large B-cell lymphoma patients who did not have those types of lymphoma.

Continue Reading

Clinical Trials at City of Hope

Hodgkin Lymphoma Trial Results Promising

January 9, 2017 | Abe Rosenberg

Everything changed when a Hodgkin lymphoma patient joined a Phase II clinical trial examining the effectiveness of brentuximab vedotin (BV) after a failed transplant. The BV worked immediately, achieving a complete remission which, year after year, proved to be durable beyond anyone's expectations.

Continue Reading

Steven Rosen

Steven T. Rosen, M.D. on the Latest Breakthroughs in Blood Cancer Treatment

December 16, 2016 | City of Hope

The long-term strategies offered by City of Hope’s Hematologic Malignancies (HM) Program have dramatically improved the lives of patients with leukemia, lymphoma, Hodgkin’s disease and multiple myeloma.

Continue Reading

breakthroughs - ASH

ASH 2016: Innovative new trials show promise for lymphoma and multiple myeloma patients

December 7, 2016 | City of Hope

Numerous clinical trials, which lay the groundwork for novel approaches to lymphoma and multiple myeloma therapies, could ultimately lead to new treatments that improve survival and quality of life for patients with those and other diseases. Additional studies give new insight into best practices for the treatment of various blood cancers.

Continue Reading

Breakthroughs - Joseph Alvarnas 256x256

Treatment for acute lymphoblastic leukemia patients has improved, but challenges persist

September 14, 2016 | Leti Marquez

Children with acute lymphoblastic leukemia (ALL) are going into remission at higher rates than ever before - thanks to better treatment that stems from leading-edge clinical trials - but adults with ALL still face significant hurdles in overcoming the disease.

Continue Reading

Back To Top